GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American:SENS) today announced that it plans to release its fourth quarter and full year 2017 financial results after market close on Tuesday, March 13, 2018.
Management will hold a conference call to review the company’s fourth quarter and full year 2017 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on Senseonics Holdings, Inc. website at www.senseonics.com by navigating to “Investor Relations,” and then “Events & Publications,” and will be archived there for future reference. To listen to the conference call, please dial 1-877-883-0383 (US/Canada) or (412) 902-6506 (International), Participant Elite Entry Number 2850172, approximately ten to five minutes prior to start time.
Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of transformational glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' first generation product, the Eversense CGM System, includes a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.